SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029393
Filing Date
2018-11-14
Accepted
2018-11-13 20:20:19
Documents
65
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arvn-10q_20180930.htm 10-Q 2128315
2 EX-31.1 arvn-ex311_9.htm EX-31.1 18212
3 EX-31.2 arvn-ex312_8.htm EX-31.2 18166
4 EX-32.1 arvn-ex321_6.htm EX-32.1 9211
5 EX-32.2 arvn-ex322_7.htm EX-32.2 9220
  Complete submission text file 0001564590-18-029393.txt   6462479

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arvn-20180930.xml EX-101.INS 1141734
7 XBRL TAXONOMY EXTENSION SCHEMA arvn-20180930.xsd EX-101.SCH 52467
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arvn-20180930_cal.xml EX-101.CAL 42924
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arvn-20180930_def.xml EX-101.DEF 216822
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arvn-20180930_lab.xml EX-101.LAB 398936
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arvn-20180930_pre.xml EX-101.PRE 329319
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38672 | Film No.: 181180027
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1